Evidence map›Paper›PMID 37250131›Full record

ArticleFrontiers in physiology2023

Alterations of the Ca

Adriana Moreno-Salgado, Nayeli Coyotl-Santiago, Roberto Moreno-Vazquez, Mayte Lopez-Teyssier, Mario Garcia-Carrasco, Francesco Moccia, Roberto Berra-Romani

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in physiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Adriana Moreno-SalgadoDepartment of Biomedicine, School of Medicine, Benemerita Universidad Autonoma de Puebla, Puebla, Mexico.
Nayeli Coyotl-SantiagoDepartment of Biomedicine, School of Medicine, Benemerita Universidad Autonoma de Puebla, Puebla, Mexico.
Roberto Moreno-VazquezDepartment of Biomedicine, School of Medicine, Benemerita Universidad Autonoma de Puebla, Puebla, Mexico.
Mayte Lopez-TeyssierDepartment of Biomedicine, School of Medicine, Benemerita Universidad Autonoma de Puebla, Puebla, Mexico.
Mario Garcia-CarrascoDepartment of Immunology, School of Medicine, Benemerita Universidad Autonoma de Puebla, Puebla, Mexico.
Francesco MocciaDepartment of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, Pavia, Italy.
Roberto Berra-RomaniDepartment of Biomedicine, School of Medicine, Benemerita Universidad Autonoma de Puebla, Puebla, Mexico.
Benemérita Universidad Autónoma de Puebla · MXUniversity of Pavia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 2 Diabetes Mellitus (T2DM) is a rapidly rising disease with cardiovascular complications constituting the most common cause of death among diabetic patients. Chronic hyperglycemia can induce vascular dysfunction through damage of the components of the vascular wall, such as vascular smooth muscle cells (VSMCs), which regulate vascular tone and contribute to vascular repair and remodeling. These functions are dependent on intracellular Ca

Indexed as

freshly isolated vascular smooth muscle cellsFura-2intracellular Ca2+type 2 diabetes mellitusZucker diabetic fatty

Identifiers

PMID37250131
PMCPMC10213752
OpenAlexW4376279384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.